Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the ...

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com